CVS Health Statistics

Total Valuation

CVS Health has a market cap or net worth of MXN 1.75 trillion. The enterprise value is 3.03 trillion.

Market Cap	1.75T
Enterprise Value	3.03T

Important Dates

The next estimated earnings date is Wednesday, February 4, 2026.

Earnings Date	Feb 4, 2026
Ex-Dividend Date	Oct 23, 2025

Share Statistics

Current Share Class	1.27B
Shares Outstanding	n/a
Shares Change (YoY)	-0.37%
Shares Change (QoQ)	-0.08%
Owned by Insiders (%)	0.10%
Owned by Institutions (%)	88.71%
Float	1.27B

Valuation Ratios

The trailing PE ratio is 203.05 and the forward PE ratio is 10.85.

PE Ratio	203.05
Forward PE	10.85
PS Ratio	0.24
PB Ratio	1.30
P/TBV Ratio	n/a
P/FCF Ratio	15.13
P/OCF Ratio	10.45
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.42, with an EV/FCF ratio of 26.28.

EV / Earnings	352.59
EV / Sales	0.43
EV / EBITDA	9.42
EV / EBIT	16.43
EV / FCF	26.28

Financial Position

The company has a current ratio of 0.83, with a Debt / Equity ratio of 1.12.

Current Ratio	0.83
Quick Ratio	0.59
Debt / Equity	1.12
Debt / EBITDA	4.62
Debt / FCF	12.99
Interest Coverage	3.28

Financial Efficiency

Return on equity (ROE) is 0.58% and return on invested capital (ROIC) is 4.06%.

Return on Equity (ROE)	0.58%
Return on Assets (ROA)	2.50%
Return on Invested Capital (ROIC)	4.06%
Return on Capital Employed (ROCE)	6.24%
Revenue Per Employee	27.69M
Profits Per Employee	33,150
Employee Count	300,000
Asset Turnover	1.54
Inventory Turnover	18.54

Taxes

In the past 12 months, CVS Health has paid 45.49 billion in taxes.

Income Tax	45.49B
Effective Tax Rate	85.28%

Stock Price Statistics

The stock price has increased by +15.97% in the last 52 weeks. The beta is 0.48, so CVS Health's price volatility has been lower than the market average.

Beta (5Y)	0.48
52-Week Price Change	+15.97%
50-Day Moving Average	1,426.07
200-Day Moving Average	1,292.51
Relative Strength Index (RSI)	38.60
Average Volume (20 Days)	315

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.55

Income Statement

In the last 12 months, CVS Health had revenue of MXN 7.18 trillion and earned 8.60 billion in profits. Earnings per share was 6.80.

Revenue	7.18T
Gross Profit	959.30B
Operating Income	186.12B
Pretax Income	53.34B
Net Income	8.60B
EBITDA	270.60B
EBIT	186.12B
Earnings Per Share (EPS)	6.80

Full Income Statement

Balance Sheet

The company has 206.02 billion in cash and 1.50 trillion in debt, giving a net cash position of -1,293.49 billion.

Cash & Cash Equivalents	206.02B
Total Debt	1.50T
Net Cash	-1,293.49B
Net Cash Per Share	n/a
Equity (Book Value)	1.34T
Book Value Per Share	1,053.28
Working Capital	-285.88B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 167.08 billion and capital expenditures -51.65 billion, giving a free cash flow of 115.43 billion.

Operating Cash Flow	167.08B
Capital Expenditures	-51.65B
Free Cash Flow	115.43B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 13.35%, with operating and profit margins of 2.59% and 0.12%.

Gross Margin	13.35%
Operating Margin	2.59%
Pretax Margin	0.74%
Profit Margin	0.12%
EBITDA Margin	3.77%
EBIT Margin	2.59%
FCF Margin	1.61%

Dividends & Yields

This stock pays an annual dividend of 51.36, which amounts to a dividend yield of 3.76%.

Dividend Per Share	51.36
Dividend Yield	3.76%
Dividend Growth (YoY)	7.20%
Years of Dividend Growth	1
Payout Ratio	722.81%
Buyback Yield	0.37%
Shareholder Yield	4.14%
Earnings Yield	0.49%
FCF Yield	6.61%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

CVS Health has an Altman Z-Score of 2.18 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.18
Piotroski F-Score	6